Mark Faries, MD
Director of Melanoma Research Program and Co-Director of the JWCI Fellowship Program
Areas of Interest & Expertise
Translational Tumor Immunology
Mark B. Faries, MD, FACS, is one of the nation’s leading melanoma researchers. He has been published and has lectured extensively in regards to his research on melanoma, lymphatic metastasis, immunotherapy and other cancers.
Dr. Faries has a long history with JWCI. After completing his fellowship, he took a position as the Director of Translational Tumor Immunology, where he worked on research relating to cancer in the lymphatic system as well as melanoma and immunotherapy. He left JWCI to become an Associate Professor of Surgery and Dermatology at Yale University School of Medicine where he opened the Multicenter Selective Lymphadenectomy Trial and worked on trials of local immunotherapy.
Upon returning to JWCI, Dr. Faries will be initiating the adoptive immunotherapy program as well as working with JWCI founder Donald L. Morton, MD, to aid in the completion of the international MSLT clinical trials regarding sentinel lymph node biopsy. He is also continuing the Isolated Hepatic Perfusion research he had participated in prior to going to Yale.
Dr. Faries is currently a member of the Society of Surgical Oncology, Western Surgical Association, American College of Clinical Oncology, International Society for Biological Therapy of Cancer and American Association for Cancer Research and Fellow of the American College of Surgeons.
Haverford College, Haverford, PA.
MD, Cornell University Medical College, New York, NY.
Internship/Residency, Hospital of the University of Pennsylvania, Philadelphia, PA.
Fellowship, John Wayne Cancer Institute, Santa Monica, CA.
John Wayne Cancer Institute
2200 Santa Monica Boulevard
Santa Monica, CA 90404